Avid Bioservices to Announce Q1 Fiscal 2025 Financial Results
Avid Bioservices, Inc. (NASDAQ: CDMO), a leading biologics contract development and manufacturing organization, is set to release its financial results for the first quarter of fiscal year 2025. This significant announcement will occur after the market closes on September 9, 2024. Following this release, Avid will hold a live webcast starting at 1:30 PM Pacific Time (4:30 PM Eastern Time), where senior management will discuss the financial results and share insights on recent corporate developments.
About Avid Bioservices
Dedicated to enhancing patient lives, Avid Bioservices is focused on delivering high-quality services to biotechnology and pharmaceutical companies. Based in Tustin, California, this committed contract development and manufacturing organization (CDMO) specializes in the development and CGMP manufacturing of biologics. With over thirty years of experience, Avid plays a vital role in advancing the biopharmaceutical industry.
Comprehensive Services Offered
Avid Bioservices provides a broad range of services tailored to the biotechnology and biopharmaceutical sectors. These offerings include CGMP clinical and commercial drug substance manufacturing, bulk packaging, and support for regulatory submissions. The company is also skilled in process development activities designed for early-stage programs, which encompass essential tasks like cell line development, upstream and downstream development and optimization, as well as comprehensive analytical methods development.
Commitment to Client Partnerships
Collaboration and partnership are at the heart of Avid's mission. The company is devoted not only to developing and manufacturing products but also to ensuring that each client feels supported throughout the entire process. Whether handling standalone projects or comprehensive development and manufacturing programs aimed at commercialization, Avid Bioservices is committed to excellence in every facet of its work.
Frequently Asked Questions
1. When will Avid Bioservices report its Q1 FY 2025 financial results?
Avid Bioservices will report its financial results on September 9, 2024, after market close.
2. How can I access the financial results webcast?
The live webcast can be accessed on the company's investor relations website during the scheduled time.
3. What services does Avid Bioservices provide?
Avid offers a full range of services including CGMP manufacturing, process development, and regulatory support for biotechnology and biopharmaceutical companies.
4. Where is Avid Bioservices located?
Avid Bioservices is headquartered in Tustin, California.
5. What is the significance of CGMP in Avid's operations?
CGMP, or Current Good Manufacturing Practices, is crucial for ensuring the quality and consistency of biologics produced for clinical and commercial use.